Merkel cautions EU leaders over choice of EU Commission chief

BRUSSELS (Reuters) - German Chancellor Angela Merkel said on Friday that EU leaders could provoke a crisis if they did not take into account the views of the European Parliament when choosing the next head of the EU executive. 'We suggest the person, but we definitely don't want to see a crisis with parliament, to realise that what we suggest is not being accepted.

Reuters June 21, 2019 07:06:13 IST
Merkel cautions EU leaders over choice of EU Commission chief

Merkel cautions EU leaders over choice of EU Commission chief

BRUSSELS (Reuters) - German Chancellor Angela Merkel said on Friday that EU leaders could provoke a crisis if they did not take into account the views of the European Parliament when choosing the next head of the EU executive.

"We suggest the person, but we definitely don't want to see a crisis with parliament, to realise that what we suggest is not being accepted. This wouldn't be good for the work of the Commission in the next five years," she told reporters after leaders failed to settle on a name during their summit.

Merkel also said an agreement on top jobs should be reached before the new European Parliament meets for a first time on July 2.

(Reporting by Sabine Siebold; writing by Philip Blenkinsop)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

Gilead nears deal to buy Immunomedics for more than $20 billion, WSJ reports
Business

Gilead nears deal to buy Immunomedics for more than $20 billion, WSJ reports

(Reuters) - Gilead Sciences Inc is nearing a deal to buy biopharmaceutical company Immunomedics Inc for more than $20 billion, the Wall Street Journal reported on Saturday, citing people familiar with the matter. A deal for Immunomedics, which last month reported positive data from a late-stage study for its breast-cancer drug, could be announced Monday if not sooner, the Journal said https://www.wsj.com/articles/gilead-nears-deal-to-buy-immunomedics-for-more-than-20-billion-11599936777?mod=hp_lead_pos2. Gilead and Immunomedics did not respond immediately to emailed requests from Reuters for comment

China bans German pork imports after African swine fever case
Business

China bans German pork imports after African swine fever case

SHANGHAI (Reuters) - China banned pork imports from Germany on Saturday after it confirmed its first case of African swine fever last week, in a move set to hit German producers and push up global prices as China's meat supplies tighten. China's ban on imports from its third largest supplier comes as the world's top meat buyer deals with an unprecedented pork shortage after its own epidemic of the deadly hog disease. The ban on Germany, which has supplied about 14% of China's pork imports so far this year, will push up demand for meat from other major suppliers like the United States and Spain, boosting global prices.

Libya's Haftar committed to ending oil blockade, U.S. says
Business

Libya's Haftar committed to ending oil blockade, U.S. says

CAIRO (Reuters) - Libyan commander Khalifa Haftar has committed to ending a months-long blockade of oil facilities, the U.S.